CD7 and acute lymphoblastic leukemia: In another study, we demonstrated in vitro, in vivo, and clinical studies that naturally selected CD7 CAR-T cells can produce promising therapeutic effects in the treatment of T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma (T-ALL/LBL) [34].